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ABSTRACT  Hauswirth et al.  (1968)  proposed that epinephrine  acts on i,  by
adding its  own positive charge  to the external  membrane  surface  near  the  iK,
channel.  This hypothesis was tested by using noncationic  compounds,  theophyl-
line and R07-2956, which mimicked epinephrine's  effects on pacemaker activity
and on ix,. In maximally effective doses, theophylline or R07-2956 occluded  the
effect of epinephrine,  indicating a shared final common mechanism.  Since theo-
phylline  and  R07-2956  are  noncationic  at  pH  7.4,  the  common  mechanism
cannot be a direct change in external surface charge.  On the contrary,  epineph-
rine  does  not  interfere  with  the  voltage  shift  produced  by  La++ +,  which  is
thought  to  modify  the  external  surface  charge.  The  results  argue  against  the
original hypothesis  but leave  open  the  possibility  that an alteration  in internal
surface charge generates  the observed  voltage shift. The potency of theophylline
and  R07-2956  as phosphodiesterase  inhibitors  suggests  that the  final common
mechanism  begins with  the elevation  of intracellular cyclic AMP,  leading to a
saturable  process  which limits the voltage  shift's magnitude.  This  hypothesis  is
used  to generate  dose-response  curves  describing  the  combined  effects  of epi-
nephrine and theophylline, and these are compared with experimental data.
INTRODUCTION
The ionic basis  of epinephrine's  acceleratory  effect in cardiac  Purkinje fibers
has been examined by means of voltage clamp experiments  (Hauswirth et al.,
1968; Tsien  1974).  Epinephrine  acts rather selectively in modifying the prop-
erties of the pacemaker potassium current, ix,, whose time dependence under-
lies the diastolic pacemaker  (Noble  and Tsien,  1968).  The drug favors a more
rapid  and  more  complete  deactivation  of i,,  at any  given  potential  in  the
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diastolic voltage  range,  and  thus promotes  spontaneous  activity.  This effect
may be described to a first approximation as a "voltage shift,"  a displacement
of the voltage-dependent  kinetic parameters toward  less negative potentials.
The epinephrine-produced  voltage  shift bears  a  strong qualitative resem-
blance to the effect of elevating the calcium concentration in the bathing fluid.
In  Purkinje  fibers,  as in  other  excitable  tissues,  calcium  and  various  other
cations produce voltage  shifts in the kinetic variables  (e.g. Weidmann,  1955;
Frankenhaeuser and Hodgkin,  1957; Frankenhaeuser,  1957; Jenerick,  1959).
In the specific case of iK,,  increasing  [Ca]0 fourfold shifts the  activation curve
by about 8 mV (Noble and Tsien, unpublished; Brown,  1973). The similarity
of effects,  and  the fact that epinephrine is positively  charged,  led Hauswirth
et al.  (1968)  to suggest that epinephrine had  a "calcium-like"  mechanism  of
action.  Thus,  following  a suggestion  of A.  F.  Huxley  (Frankenhaeuser  and
Hodgkin,  1957), it was hypothesized  that epinephrine  directly altered the ex-
ternal surface charge and local electric field near the iK, channel.  The change
in the electric  field would  bias the activation  process toward  the deactivated
state, so that a stronger depolarization would be required to activate  i,.  The
extreme sensitivity of i,  to epinephrine,  and  the insensitivity  of iN,  (Traut-
wein  and  Schmidt,  1960)  could  be  accounted  for  if the  catecholamine  pos-
sessed  a high affinity  for a specific  site on or near the i,  channel.
What criteria can  be used to test the idea  of a directly effective  alteration
of the external surface charge? The effects  of changes in surface charge  have
been  considered  in  various  theoretical  treatments  (e.g.  Gilbert  and  Ehren-
stein,  1969; Brown,  1974).  Specific locations for the added charge are assumed
in each case, but the models do not help in settling the question of its location.
Any  scheme  (say,  positive charge  on  the outside  membrane  surface)  can  be
reformulated for the opposite case  (negative charge on the inside surface),  and
still give rise to an appropriate  voltage shift. Thus, the existing theory neither
supports nor rules out the external surface charge  hypothesis.
Another  possible  approach  is to study the hormone effect  as  a function of
pH, to see if the effect  declines as the drug molecules are neutralized  in alka-
line  solutions.  Unfortunately,  this  type  of experiment  is  rather  impractical
since  in catecholamines  the pK.'s are near  10.  In any case, the results would
be ambiguous;  they might show that the drug acted in the cationic form,  but
this would not settle the question of whether the cationic form directly altered
the electric  field sensed by the iK, channel.
This paper reports  the results of a  less direct  approach to  the hypothesis,
which  nevertheless  provides  evidence concerning  its  validity.  I have studied
the effects of two chronotropic agents,  theophylline and R07-2956,  which are
often  employed  as inhibitors  of intracellular  phosphodiesterase.  These  com-
pounds  are  interesting  in  the  present context  because  it turns out  that they
have epinephrine-like  actions on iK,,  despite the fact that the molecules are vir-
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tually uncharged at physiological pH. Studies of the effects of theophylline and
R07-2956,  individually,  and  in  combination with epinephrine,  demonstrate
that these  agents  share  a final  common  mode  of action with  the  hormone.
Since theophylline and R07-2956  are not cations, it is concluded that the final
action  cannot  be  a  simple  and  direct  modification  of the  external  surface
charge,  as originally hypothesized by Hauswirth et al.  (1968).  To replace  the
original hypothesis, it is proposed that the final common mode of action of epi-
nephrine and phosphodiesterase  inhibitors involves intracellular cyclic  AMP,
and  that cyclic  AMP in some way  mediates  the effect  on  i 2. The  dose  de-
pendence  of the epinephrine  effect  is reinterpreted  in terms of a quantitative
scheme  involving  cyclic  AMP.  Some  aspects  of this  work  have  already  ap-
peared  in a  preliminary  communication  to  the British Physiological  Society
(Tsien,  1973 b).
METHODS
The experiments in this paper compare the action of three chronotropic  agents whose
chemical formulae  are shown in Fig.  1. Epinephrine  bears a single positive charge on
the amine  group  at the pH  used in  these experiments  (7.2-7.4).  The  action  of epi-
nephrine  has  been related  to  the  effects of two other  compounds,  theophylline  and
R07-2956,  also indicated  in  Fig.  1. Theophylline  is  a methylxanthine  and at physio-
logical pH the concentration  of the cationic form is negligible  (pK  =  0.9). Some 5 %
is present as anion  (see Hardman,  1962).  This compound has been widely used in bio-
chemical studies as an inhibitor of phosphodiesterase  and it is known to have inotropic
effects  in  heart  (e.g.  Rall  and  West,  1963;  Blinks et  al.,  1972).  Finally,  R07-2956
(4-(3,4-dimethoxybenzyl)-2-imidazolidinone)  is also  a potent phosphodiesterase  in-
hibitor  (Sheppard  and Wiggan,  1970)  but its chemical  structure  is  distinct from the
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FIGURE  . The structure of the chronotropic agents used  in the experiments. At physio-
logical pH epinephrine bears a single positive charge, but theophylline and R07-2956 are
noncationic.
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methylxanthines.  Unlike theophylline or caffeine, R07-2956  does not appear to cause
the  release  of calcium from  intracellular  stores, judging from its ineffectiveness  as a
modifier  of mechanical  activity in single frog skeletal muscle fibers  (H.  Oetliker and
Tsien,  unpublished),  even in maximal concentrations  (approx. 2  mM).  R07-2956  is
also uncharged at physiological  pH.
The compounds  were obtained from the following  sources:  epinephrine bitartrate
(Sigma  Chemical  Co.,  St.  Louis,  Mo.),  theophylline  (Sigma)  and  R07-2956  (Hoff-
man-LaRoche, Nutley, N. J.). Theophylline- and R07-2956-containing  solutions were
made up from concentrated stock solutions which were stored in a refrigerator for pro-
longed  periods  without loss of activity.  Epinephrine  solutions  were  freshly  made up
during the course of the experiments  and contained 4 X  10- 5 M Na2 EDTA to retard
oxidation. The experimental methods were similar to those used in the previous paper
(Tsien,  1974).
RESULTS
The electrophysiological  effects  of both theophylline  and  R07-2956  are very
similar to the actions of epinephrine. Fig. 2 shows a pen recording of the trans-
membrane  potential  in  a  calf  Purkinje fiber  preparation and the  effect  of
R07-2956  (44 ,uM). The upper panel shows stimulated action potentials on a
I  min
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is
FIGURE  2.  Effect  of R07-2956  on  electrical  activity.  Transmembrane  potential  is  re-
corded  by a chart recorder on a slow time base  (upper panel) and on an expanded  time
base  (lower panel).  The upper panel initially  shows externally stimulated  action poten-
tials  (4/min).  At  the  arrow  the  superfusing  solution  was  changed  to  one  containing
R07-2956  (44  M).  The  diastolic depolarization  progressively  increases and full-blown
spontaneous activity soon follows.  The lower panel compares the activity before  (trace 1)
and 3 min after (trace 2) beginning the exposure to R07-2956. Apart from the appearance
of spontaneous activity, there is an elevation of the plateau level and a decrease in action
potential  duration. Preparation  53-5 in 1.8 mM [Ca]o.
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slow time base before drug exposure. There was some diastolic depolarization,
but no spontaneous  activity; this behavior is typical in 4 mM [K],. The solu-
tion was  changed  from normal  Tyrode's  to drug-containing  solution  at  the
time marked  by the arrow; after some delay  (due in part to dead space in the
superfusion system) the magnitude of the diastolic depolarization progressively
increased  and  soon led to full-blown  pacemaker  activity.  This pattern  of be-
havior was also observed in each of seven preparations which were exposed to
theophylline  (0.2  mM or greater)  and  was very similar  to  the chronotropic
effect  of epinephrine.
The  changes  in  the  action  potential  and  pacemaker  potential  are  more
clearly seen in the lower panel of Fig. 2,  which shows photographically  super-
imposed recordings  on a faster time base from the same experiment.  Trace  1
is  the externally  stimulated  action  potential  under  control  conditions,  and
trace  2 is the spontaneous  action potential during exposure to R07-2956.  Be-
sides the obvious increase in the steepness of the diastolic depolarization,  there
are changes  in the configuration  of the plateau  as well.  These also resemble
the effects produced  by epinephrine  (Tsien et al.,  1972),  but they will not be
considered in this paper since  they do not involve the pacemaker  K current.
The observation that R07-2956 and theophylline produce epinephrine-like
effects  on  electrical  activity  leads naturally  to the  question  of whether  these
compounds mimic epinephrine  at the level  of individual ionic currents.  Volt-
age clamp experiments were carried out to test the effect of these agents on the
pacemaker  potassium current, i, 2, which underlies the pacemaker  depolariza-
tion.  Fig.  3  (top panel)  shows that R07-2956  produces  a voltage  shift in  the
activation curve of i,,. A concentration  of 500  M is only slightly more  effec-
tive than  100 jiM R07-2956, suggesting that the maximal voltage shift was at-
tained. The magnitude of the maximal shift,  17 mV, corresponds  quite well to
the average maximal shift produced by epinephrine  (Tsien,  1974).  The thresh-
old for detectable activation of the excitatory sodium current was not affected;
the  level  of background  current  (when  iK 2 is  fully  deactivated)  is  also  un-
changed.
The  lower  panel  of Fig.  3  shows  that the  fully  activated  current-voltage
relationship  of iK is unaltered by  R07-2956.  The absence of a change  in  the
rectifying characteristic  is similar to the lack of change seen with epinephrine.
It is clear, therefore, that the chronotropic action of R07-2956 is confined to an
alteration in the kinetics of i,,; in this specificity  of action, R07-2956  strongly
resembles  epinephrine.
The  effects  of theophylline  on  i,,  were  also studied  under  voltage  clamp
conditions. As in the case of the other chronotropic agents, the activation curve
for i,K  is shifted toward less negative potentials by about 20 mV  (Fig. 4,  lower
panel).  The  effect  of  theophylline  on  the  rate  of change  of  the  pacemaker
current is indicated in the upper panel. The left-hand limb of the rate constant
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FIGURE  3.  The effect of R07-2956 on the pacemaker  potassium current,  ik  The steady-
state  activation curve  (top panel)  is  shifted  toward  less  negative  potentials by the drug
(arrows  denote midpoint  voltage,  V). The fully activated  current voltage relationship,
iK,  (lower panel) appears  unchanged.  See Fig. 7 of previous paper for further description
of this type of data.
curve is displaced to a much smaller degree than the right-hand limb.  In  this
deviation  from simple voltage shift  behavior,  the effects  of theophylline  and
epinephrine  are quite similar  (see  Table I,  Tsien,  1974).  On the other hand,
the activation curve is not steepened in this case, although in some experiments
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FIGURE  4.  The effect of theophylline on the kinetics of iK2. (Top) Rate constant data in
the presence  of 0.5 mM  theophylline,  and  in  a control  run after washing  off  the drug.
Open  symbols  show direct measurements  of the exponential  time constant  of decaying
ix2 current  (as in Fig. 3, previous paper).  Filled symbols are obtained by fitting the enve-
lope  of tails  after  pulses  to  the  indicated  test potentials  (see  Fig.  5,  previous  paper).
Smooth curves drawn by eye through points.  (Bottom)  The steady-state activation curve
in the presence of theophylline,  and in the subsequent control run. The vertical scales  on
the right-hand side  give the magnitude of the tail  currents measured  at the holding  po-
tential (-80 mV)  in the respective  solutions.  The  left-hand  scale  gives  the normalized
degree of activation. The data are presented  in this form to allow direct comparison with
Figs. 2 and 3 of Hauswirth et al.  (1968). Experiment 52-1,  1.8 mM [Ca]o.
Do the Actions of  These Chronotropic  Agents  Coincide?
The  epinephrine-like  effects  of theophylline  and  R07-2956  might  be rather
trivial if they took place  (a) through the release  of endogenous catecholamines
in fine nerve endings, or (b) through the direct stimulation of the fl-adrenergic
receptor.  These  possibilities  can  be  ruled  out  by  my  observation  that  the
chronotropic  effects of theophylline  (two experiments)  or R07-2956  (two ex-
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periments)  cannot be prevented  by the presence of  10-6  M propranolol,  even
though this treatment  does block the effect of epinephrine  (Davis and Temte,
1968; Tsien,  1974).  It is evident, therefore,  that the modes of action of theoph-
ylline or R07-2956 do not completely  coincide  with that of epinephrine.
A Final  Common Mechanism?
The differential effect of propranolol does not preclude the possibility that the
various chronotropic  agents  share a common  mechanism at some later stage.
This  question  was  examined  by  studying  the  effects  of  theophylline  and
R07-2956  in combination  with epinephrine.
Fig.  5  (top)  plots the  midpoint  voltage  (V.)  of the pacemaker  potassium
current  during  successive  exposures  to  different  drug-containing  solutions.
Large  concentrations  of  epinephrine  (10-5  M)  and  theophylline  (2  mM)
were employed individually  and in combination.  The plot shows that,  in the
presence of  10- 5 M epinephrine,  2 mM theophylline produced  no additional
shift  in  V.  Removal  of both  compounds  abolished  the  shift.  Subsequent
addition of theophylline  (2 mM)  alone restored  the full magnitude  of voltage
shift.  Now,  the  addition  of epinephrine  (10-6  M)  produced  no  additional
shift.  Finally,  removal  of both compounds  gave  a nearly complete  return to
the unshifted state.  Fig.  5  (bottom)  shows  a similar result  using epinephrine
and  R07-2956.
This type of experiment can be summarized by the statement that epineph-
rine and theophylline (or R07-2956)  are mutually  occlusive. Each compound
is individually  capable of eliciting the maximal voltage shift. The result indi-
cates  that  epinephrine  does,  in  fact,  share  some  final  common  mechanism
with the noncationic compounds,  and that each compound  is able to saturate
this mechanism.
Stated diagramatically,
propranolol
epinephrine  //
voltage  shift  acceleratory
/  in i  activation  effect
theophylline
or R07-2956
The diagram leaves open the question of whether the final common mecha-
nism consists of a single step or a number of steps. But  the mere existence of
a final  common mechanism  is significant,  since it argues against the hypothe-
sis  of Hauswirth et al.  (1968).
Additive Effects  of Epinephrine and La+++  on i,,
A  possible  objection  to  the  previous  experiment  is  that  the  extent  of  the
voltage  shift  is restricted  under  all  circumstances  by some  factor which  has
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FIGURE  5.  Effects of chronotropic agents,  individually  and  in combination.  The mid-
point voltage  of the steady-state  activation  curve  (V 8)  is  indicated  by  the vertical  axis.
Each point corresponds  to a separate determination  of Vs  during maintained  exposure to
a drug solution,  or in  the absence  of chronotropic agents  (open  symbols).  Consecutive
determinations  are plotted from left to right.  (Top) Mutually occlusive effects of epineph-
rine  (10- 5M)  and  theophylline  (2  mM).  Preparation  79-4  in  1.8 mM  [Ca]o.  (Bottom)
Mutually occlusive effects of epinephrine  (10- 5M) and R07-2956  (0.5 mM).  Preparation
105-2  in  5.4 mM  [Ca],. D600  (5  X  10- 7 g/ml) was  used  to  inhibit contractions  in  all
solutions except  the initial control.  Propranolol  (10-6 M) was present in the second con-
trol run, and hastened  the removal of the previous epinephrine effect.
little to do with the mode  of action of the individual compounds.  This criti-
cism  can  be  overcome  by showing  that  some  other  agents  can  produce  a
voltage shift over and above the effect  of epinephrine.
If  epinephrine does  not act by a direct modification  of the external surface
charge  near  the  i  channel,  it  should  not  interfere  with the  voltage  shift
produced  by  multivalent  cations.  These  are thought  to  act,  at least in part,
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by  modifying  the  external  surface  charge  (Frankenhaeuser  and  Hodgkin,
1957;  Gilbert  and  Ehrenstein,  1969).  Among  multivalent  cations,  the  most
obvious  choice  would  be  calcium  ion,  since  its  voltage shift-producing  be-
havior  is well  known,  and because  increases  in [Ca],  do shift  the  activation
curve of iK, (Noble  and Tsien, unpublished;  Brown,  1973).  There  are special
difficulties with using calcium,  however,  since the combination of epinephrine
and a  high  calcium  concentration  gives  rise to vigorous  contractions  which
often dislodge  the microelectrodes.  To avoid these  problems it  is convenient
to use another multivalent cation,  La+++.  Mole-for-mole,  lanthanum is much
more potent than calcium in producing voltage shifts in Hodgkin-Huxley-type
processes.  Its mechanism  of action  is thought  to be a  direct  binding  to  the
external  membrane  surface  as  originally  proposed  for  calcium  (Franken-
haeuser and Hodgkin,  1957),  and like calcium,  lanthanum shifts both  iK, and
iNs  in  Purkinje  fibers.  Unlike  calcium,  however,  La+++  does  not  promote
vigorous  contractile  activity.  On  the  contrary,  it  suppresses  the  twitch  in
Purkinje  fibers  (probably  through  its  interference  with  the  inward  move-
ment of calcium ions via the secondary inward current).
Fig.  6 shows  an experiment  where  the  effect  of La+++  was determined  in
the  absence,  and  then  in  the  presence  of epinephrine.  As  in  the  previous
figure,  the ordinate plots  V,,  the midpoint of the  iK, activation  curve. In the
absence  of the catecholamine,  exposure to La+++  gives a 7.5-mV shift (deter-
mined using the mean  of the control  V, values  before and  after  La+++ expo-
vs
(mV)
FIGURE  6.  The effect  of LaCI 3 (0.5  mM)  in the  absence  (open symbols)  and presence
(filled  symbols)  of epinephrine.  Voltage  shifts are plotted  as vertical displacements.  Ex-
periment 94-1  in 5.4 mM  [Ca]o,  with D600  (5  X  10- 7 g/ml) in  La+++-free  solutions to
inhibit contractions.
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sure).  The preparation  was then superfused with solution containing a maxi-
mally  effective  dose  of  epinephrine  (10-6  M),  which  produced  a  typical
voltage shift.  In the maintained presence  of epinephrine,  the preparation  was
then reexposed  to 0.5 mM La+++.  In this case  a 9.8-mV shift was produced.
The  experiment  shows  that the  La+++ voltage  shift  is  not  occluded  by  the
presence  of  epinephrine.  The  result  stands  in  obvious  contrast  with  the
mutual occlusion observed between epinephrine and theophylline, or epineph-
rine and R07-2956.
The additive  effects of epinephrine and La+++  provide further evidence on
the mechanism  of the  hormone  action.  Suppose that La+++ and  epinephrine
each produced voltage shifts by putting their  own charge near the i, 2 channel.
Even  if there  were  separate  binding sites  for each  cation,  some  interaction
between  their  effects  would  be  expected,  since  each  cation  must  be  close
enough to the activation process to give substantial voltage shifts individually.
According  to this  argument, the  presence  of epinephrine  should  reduce  the
local  [La+++ ] near the  channel,  and,  therefore,  the amount  of La+++  bound
(the  applied  dose of La+++ is far from giving  a saturated  effect).  The  effect
of epinephrine  on  [La+++]it.  can  be  roughly  estimated  if the La+ + + bind-
ing site  experiences  a surface  potential  change  as  large  as  the  net  voltage
shift  (A-V).  Then,  [La+++]i'/[La+++]°i ° t  =  exp(-zFAV 8/RT).  For
z  =  +3 and  V,  =  17 mV  (as in Fig. 6),  the Boltzmann factor is exp(-2)  =
0.135.  Thus,  a  large  reduction in  the  amount  of bound  La+++  would  have
been  expected if epinephrine  had, in fact,  put its own charge  near the chan-
nel.  The experiment  shows  that the  effect  of La+++  is not  diminished,  and
argues against the idea that epinephrine  modifies the external surface charge
in the immediate  vicinity of the channel.
An  Alternative Hypothesis  for the Action of Epinephrine
The epinephrine-like  action  of theophylline and R07-2956 comes  as no great
surprise  from  the biochemical  point  of view.  Both  of these  compounds  are
potent inhibitors  of 3',5'-phosphodiesterase,  the  intracellular  enzyme  which
hydrolyzes  adenosine  3' ,5'-monophosphate  (cyclic  AMP).  The conventional
interpretation  of their  effects  (see,  e.g.  Robison  et  al.,  1971)  explains  their
effects  through  the elevation  of intracellular  cyclic AMP levels.  To state  the
hypothesis diagramatically:
propranolol  rate of
epinephrine  //  ,  cAMP
formation  elevated  saturable  voltage
[cAMP]  t  step(s)  shift
rate  of  j
theophylline - *  cAMP
breakdown
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The  hypothesis  proposes  that  the final  common  mechanism  begins  with an
increase  in  the intracellular  level  of cyclic  AMP,  which eventually  leads  to
the shift in the voltage dependence  of iK,.  The mutual  occlusion of epineph-
rine  and  theophylline  is  accounted  for  by the  existence  of some  saturable
process  downstream to the elevated [cAMP]i.  The model  presumes  that either
epinephrine,  theophylline,  or  R07-2956  can  elevate  [cAMP],  beyond  the
level  required  to  saturate  the  hypothetical  process,  so  that  each  of these
agents is individually  capable  of evoking the maximal effect.
Synergistic Effects of Eiinephrine and Theophylline
In the  above experiments  epinephrine  and  theophylline were  used  in maxi-
mally  effective  concentrations.  At  low  concentrations,  however,  the  model
gives rise to the expectation  that epinephrine and theophylline  will act syner-
gistically  in  elevating [cAMP]i  and  in  producing  an  accompanying  voltage
shift. This intuitive expectation is supported by the Appendix,  which puts the
cyclic AMP scheme in quantitative  terms.
Fig.  7 shows  the  combined  results  from  seven preparations.  In three  ex-
periments,  the normalized  dose-response  curve to epinephrine  was obtained
in the presence  of a submaximal dose of theophylline  (10- 4 M).  These results
(open  symbols)  are  compared  with  results  in  the  absence  of theophylline
(filled symbols),  replotted from Fig.  9 of the previous paper. By itself,  10-
4 M
theophylline  produces a voltage  shift (points on  ordinate)  that is about  one-
third of the maximal  effect.  The addition  of epinephrine  (in the maintained
presence  of theophylline)  leads to a further voltage shift  (points at 3  X  10-8
M).  Increasing  the epinephrine  concentration to  10- 7 M gives  an essentially
maximal  effect  (compare  open  symbols at  10- ' M  and  10-6  M).  Thus,  the
dose-response curve  for epinephrine  is modified  by the presence  of theophyl-
line.
The experimental  points in Fig. 7 have  been  fitted by quantitative predic-
tions  arising  from  the  cyclic  AMP  hypothesis  (see Appendix).  The  curve
fitting was carried out in the following way.  First, the theophylline-free  data
were fitted by eye to the theoretical  control curve  (see Fig.  9 C) which holds
for the normal degree of phosphodiesterase  activity.  The fit  is made by speci-
fying  that  half-occupation  of  the  -receptor  occurs  at  an  epinephrine  con-
centration of  1.88  X  10-
7 M (vertical  arrow).
Thus  1/K,  =  1.88  X  10- 7 M, and the normalized  abscissa in Fig. 9 C can
be reexpressed  in terms  of actual  epinephrine  concentrations.  The next step
is  to fit  the data obtained  in the presence  of 10- 4 M theophylline.  This was
done  by choosing  a  value  of k2 (=  0.625)  and the  corresponding  curve  in
Fig.  9  C.  The  chosen  value  corresponds  to reduction  of phosphodiesterase
activity to /  normal.  It is evident in Fig.  7 that the adjustment of the single
parameter,  k2,  gives  a fairly  good fit to the data points,  both  in the absence
of epinephrine,  and in the presence of the range of epinephrine  concentrations.
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FIGURE  7.  Epinephrine  dose-response  curves  in the absence  and  presence of theophyl-
line.  The  ordinate  gives  the normalized  voltage  shift, AV 8/AV,;  the  abscissa  plots the
epinephrine concentration  on a  log scale.  The  different  symbols signify seven  individual
preparations.  Open  symbols  are  results  in  the presence  of  10 - 4 M  theophylline,  filled
symbols in the absence of theophylline.  [Ca]o  =  5.4 mM throughout. The smooth curves
are generated by the model described in the Appendix  (for further description  see text).
In this respect,  the experimental  results are in reasonable  agreement with the
predictions of the cyclic AMP  model.
DISCUSSION
Explanations of Epinephrine's Action
The original  aim of the  experiments was  to test the most simple explanation
for epinephrine's ability to shift the activation curve for i,  along the  voltage
axis. As Hauswirth et al.  (1968) proposed,  the voltage shift could be accounted
for if epinephrine  added  its  own positive  charge  to the  outside  of the mem-
brane  near  the  i,  channel.  This  mechanism  of  action  can  be  effectively
ruled  out by two types  of experiment.
The first experiment  compares  the action of epinephrine  with the effect  of
theophylline  or  R07-2956.  In  maximally  effective  concentrations,  these
agents  occlude  epinephrine's  action indicating  that a final  common  mode of
action is  shared.  Since  theophylline  or R07-2956  are not cations  at pH 7.4
this finding is not compatible with the original hypothesis. The second experi-
ment studies  the  action  of epinephrine  in combination with an  agent  which
is thought  to  modify  external  surface  charge:  lanthanum  ion.  In this case
the voltage shift produced  by La+ + + simply adds to the maximal epinephrine
voltage  shift:  no  occlusion  occurs.  This  result  is  also  contradictory  to  the
expectations  of the external  surface charge  hypothesis,  which predicts partial
occlusion  of the La+++  effect.
It  appears  that the  direct  external  surface  charge  explanation,  for  all  its
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simplicity,  must be abandoned.  This removes the necessity for explaining  the
fact  that  -blockers  such  as  propranolol  or  pronethalol  do  not  produce
voltage  shifts  (Hauswirth  et al.,  1968; Tsien,  1974).  From the  point of view
of the original hypothesis, their lack of effect  as voltage  shifters was awkward
since  they  are  positively  charged  molecules  that  presumably  compete  for
the same receptor that binds epinephrine.
FURTHER  CONCLUSIONS  The experiments  show that the initial effects  of
theophylline  or  R07-2956  are  propranolol  insensitive,  and,  therefore,  not
identical with the  initial action of epinephrine.  Since  the final action of epi-
nephrine does coincide with that of the other compounds,  it follows that there
are at least two steps in epinephrine's  mechanism  of action  (see diagram on
p.  327).  If it is accepted  that a sequence  of steps takes place,  the results do
not argue  against the idea  that epinephrine's  initial  action  does,  in fact,  in-
volve  a  change  in  external  surface  charge  at  some  distance  from  the  iK,
channel.  It seems  entirely  possible  that  a  change  in  surface  potential  plays
some  part in  the  interaction  of epinephrine  with the  t-adrenergic  receptor.
There  is no evidence  that I know of which  suggests  that catecholamines  act
in anything but the cationic form.
Possibility of Internal Surface Charge Mechanism
The  results  in  this  paper  leave  open  the  possibility  that  a  change  in  the
internal  surface  charge  gives  rise to the  voltage  shift.  Such  an  explanation
retains the electrostatic  character of the original scheme:  as  in the presumed
action  of  calcium  (Frankenhaeuser  and  Hodgkin,  1957),  no  change  is  re-
quired in the gating reaction itself.  Whether outside or inside, the postulated
changes in surface charge  would  merely  alter the electric  field that is  sensed
by the gating reaction.
How might  the internal  surface  charge  be altered?  One  hypothesis is that
epinephrine  brings  about  a  specific  and  direct  phosphorylation of the  inside
membrane  surface near the i,  channel  (Tsien,  1973  a). Another  explanation
is that epinephrine  leads to an increased rate of calcium uptake by the sarco-
plasmic reticulum, a fall in the free intracellular calcium concentration  and  a
removal of calcium from specific binding sites near  the i,,  channel  (McNaugh-
ton  and  Noble,  1973).  Both  of these  schemes  attempt  to  account  for  the
voltage shift by the net removal of positive charge from the inside of the mem-
brane: it follows that the electrostatic effects of the proposed mechanisms would
be  indistinguishable.  It will  be  interesting  to  see  if either  of these  internal
surface charge hypotheses survive the test of further experiments.
Possible Involvement  of Cyclic AMP
A  common  feature  of  the  two  internal  surface  charge  hypotheses  is  their
reliance  on cyclic AMP as a mediator of the effect  of epinephrine  (see Tsien,
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1973  a; McNaughton  and  Noble,  1973).  This raises  the  more  general  issue
of the  possible  role  of cyclic  AMP  as a mediator  of the  iK, voltage  shift.  A
variety  of  experimental  evidence  is  relevant  to  this  question  and  will  be
briefly  mentioned  here.
Until  recently  there  has  been  no biochemical  data  on  cyclic AMP levels
in Purkinje  fibers.  Danilo et al.  (1974)  have shown that epinephrine  elevates
cyclic  AMP  levels  in  intact  Purkinje  fibers  from  dog  heart,  as  well  as  in-
creases  adenylate cyclase  activity  in fiber  homogenates  (Danilo et al.,  1973).
The  observed  increase  falls short  of the fivefold elevation  found  in perfused
rat hearts (Robison et al.,  1965;  Cheung and Williamson,  1965)  but there  is
considerable variability both in the basal cyclic AMP level and the percentage
increase  with  exposure  to  epinephrine.  The  results  of Danilo  et  al.  (1973,
1974)  raise  the possibility  of quantitative  revision  of parameter  values  used
in the prediction of dose-response  curves (Appendix).  However, their findings
are generally  consistent with the cyclic AMP  hypothesis.
If cyclic AMP mediates the effect of epinephrine,  it is expected that similar
action should be produced by other  agents which elevate cyclic AMP levels.
Compounds  which  inhibit  3' ,5'-phosphodiesterase  are  known  to have  epi-
nephrine-like  effects in many tissues,  including heart,  and  it is generally  pre-
sumed  (although not proven)  that these agents  act by elevating cyclic  AMP.
The  present  results  show  that  two  chemically  unrelated  phosphodiesterase
inhibitors,  theophylline and R07-2956, each mimic the action of epinephrine
on  the  pacemaker  potential,  and  on  the  underlying  slow  current  changes.
The effect  of these  compounds  on  ix, is certainly  consistent with the  cyclic
AMP hypothesis.
Exposure  of cells to butyryl derivatives of cyclic AMP is another procedure
which has often  succeeded  in giving epinephrine-like  effects in intact  tissues,
although the mechanism  of this action is not clear  (see Robison et al.,  1971).
Borasio  and  Vassalle  (1971)  studied  the  effect  of N6,  2'-O-dibutyryl  cyclic
AMP  (DBcAMP)  on  automaticity  in  dog  Purkinje  preparations.  These
workers  found  effects  which  could  be  attributed  to  indirect  actions  (e.g.
release  of  catecholamines  from  fine nerve  terminals)  but no  direct  effect  of
DBcAMP itself. I have  confirmed this negative result,  using N6-monobutyryl
cyclic AMP  (MBcAMP)  as well as DBcAMP, in concentrations up to 2 mM.
The insensitivity  of the pacemaker  (and also  i,)  to  cyclic AMP  derivatives
is particularly puzzling since, in the same preparations,  dramatic  changes  in
the plateau currents  are observed  at considerably  lower  doses  of MBcAMP
(Tsien et al.,  1972).  It may yet be possible to reconcile  the apparent ineffec-
tiveness  of cyclic AMP  derivatives  with the  cyclic  AMP  hypothesis.  For ex-
ample,  it is  conceivable  that DBcAMP  and  MBcAMP  have  limited  access
to the site of action within  the cell.  Until some explanation  is  established,  it
seems premature to fully accept the idea that cyclic AMP mediates the action
of epinephrine  on  i,  although  most of the evidence  favors this  hypothesis.
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In this light the present scheme  (Appendix)  is  offered  as a tentative  frame-
work for studying the dose-dependent  effects of chronotropic  agents.
LOCATION  OF  THE  SATURABLE  PROCESS  A  key  feature  of the  proposed
scheme  (Appendix)  is that  the magnitude  of voltage  shift  is limited  by the
saturation  of some  process  downstream to  the  elevation  in  cyclic AMP;  the
location  of  the  saturable  process  is  important  in  explaining  the  mutual
occlusion  of epinephrine  and theophylline.  If the scheme is correct,  it  follows
that  the  concentration  of cyclic  AMP should  continue  to  increase  beyond
the point at which the voltage shift attains its maximum value. This expecta-
tion is supported by the results in Fig. 9 of the previous  paper (Tsien,  1974).
The maximal  voltage shift of i,  is  reached  at  10-6 M  epinephrine,  whereas
the  enhancement  of the secondary  inward  current  is  well  short  of maximal
at that point.  Since there is rather clear evidence  to indicate that the effect of
epinephrine  on  the secondary inward current  is  cyclic AMP mediated  (Car-
meliet  and  Vereecke,  1969;  Tsien  et  al.,  1972)  it  appears  that  the  cyclic
AMP level must still be increasing at an epinephrine  concentration of 10-6 M.
NATURE  OF  THE  SATURABLE  PROCESS  The  scheme  presented  in  the
Appendix does not specify the details  of the "enzyme  system" which incorpo-
rates the saturable  process.  The only requirement  is that the  end effect,  the
voltage  shift,  should saturate rather abruptly with increasing  levels of cyclic
AMP.  Of the many possibilities,  two biochemical mechanisms  may be men-
tioned  since both  of these  are  linked  to the previous  discussion  of internal
surface charge.  In one hypothesis  (Tsien,  1973 a), cyclic AMP would activate
a protein kinase which brings about the phosphorylation  of the  inside of the
membrane near the channel. This mechanism  is relatively direct but it would
be difficult to study experimentally.  The other hypothesis  (McNaughton  and
Noble,  1973)  proposes  the  removal  of Ca++ from specific  binding sites near
the  channel,  through  stimulation  of calcium  uptake  by  the  sarcoplasmic
reticulum  (SR). This idea also depends upon a cyclic AMP-activated  protein
kinase;  cyclic  AMP increases  calcium  uptake  by SR  microsomes  (Entman,
et  al.,  1969)  by  promoting  phosphorylation  of SR  membrane  by  protein
kinase  (Kirchberger  et  al.,  1972).  The calcium  removal  hypothesis  calls  for
more  steps  than  the  other  mechanism,  but  it lends  itself readily  to experi-
mental  test by  procedures  which  alter  [Ca] i  (see  McNaughton  and  Noble,
1973).
On the Dose Dependence of Chronotropic Effects
on the Pacemaker K Current
APPENDIX
The  concentration-dependent  effects  of chronotropic  agents  on  i,,  are  in-
terpreted in terms  of a  simple reaction  scheme  (Fig.  8).  It  is  proposed  that
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Catecholamine  +  AC  - AC*  - k 1 unshifted  Vs [E]
cyclic  AMP  +  system  >
[A] 
Phosphodiesterase  +  PDE-  - PDE  k2 shifted V s
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IT]
5'AMP
FIGURE  8.  A  simple  scheme  for describing  the  combined  effects  of epinephrine  and
theophylline.  Two-way arrows (-)  signify reversible  reactions, while broad arrows  indi-
cate  enzymatic  control  of a  reaction.  The nature of the enzyme  system  is  not  specified
(see  Discussion)  and  may  consist  of  a  number  of  steps.
the  actions  of catecholamines  (e.g.  epinephrine)  and  phosphodiesterase  in-
hibitors  (e.g.  theophylline)  are  mediated  by  elevations  in  the  intracellular
level  of cyclic  AMP. The  increase in [cAMP]i  in turn gives  rise to the volt-
age  shift,  via  a  saturable  process or  processes  (labeled  "enzyme  system"  in
Fig.  8).  From  this scheme  a family  of theoretical  dose-response  curves is  de-
rived.  The rationale  and background  to this scheme  is described  elsewhere;
this  appendix  merely  puts  the  model  in  quantitative  terms.
It  is assumed  that catecholamines  combine with the  -adrenergic  receptor
in  a one-for-one  fashion,  converting  the associated enzyme  adenylate cyclase
(AC)  to  an  activated  form  (AC*).  The  proportion  of  activated  adenylate
cyclase  is then
AC*/(AC +  AC*)  =  1/(1  +  E-'),  (1)
where the normalized  catecholamine  concentration  is E  =  [catecholamine]-
Kr,  and  K,  [M - 1] is the  binding constant  of the catecholamine  for the  -re-
ceptor.  The  associated  enzyme,  adenylate  cyclase,  catalyzes  the  reaction
ATP  --  cyclic  AMP  +  pyrophosphate,  with rate  coefficient  k.  Using nor-
malized  units, the  activity of adenylate cyclase  in unstimulated  form  (100%
AC)  is  called  1, and  the  fully  stimulated  activity  (100%  AC*)  is called  F.
Then, the rate coefficient  kl will  be given by
k  =  1 +  (F-  1)/(1  +  E-').  (2)
In other words,  as  [catecholamine]  increases,  k  increases  from  1 to F  along
a  hyperbolic  curve.  F  is  assigned  the  value  5  on  the  basis  of biochemical
studies  of  cyclic  AMP  levels  in  perfused  rat heart  (Robison  et  al.,  1965;
Cheung and Williamson,  1965).  For simplicity it is assumed  (cf.  Cheung and
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Williamson,  1965)  that elevations  of cyclic AMP  are steadily  maintained  in
the  continued  presence  of catecholamine.
In the scheme  phosphodiesterase  inhibitors  act through  their effect  on k2,
the  rate  coefficient  of cyclic AMP breakdown.  The inhibitor  is assumed  to
combine  with  phosphodiesterase,  converting  it  from  a  more  active  form
(PDE*)  to  a  less  active  form  (PDE).  If  the  uninhibited  activity  (100%
PDE*)  is  called  1, the  presence  of  inhibitor  reduces  k2 to  some  value  less
than  1. This  behavior  will be treated  more quantitatively  at the end  of the
Appendix.
The steady-state  level  of cyclic AMP [A]  is given by
[A]  =  k[ATP]/k2. (3)
The intracellular concentration  of ATP is normally controlled  within narrow
limits by metabolic processes  and may be normalized  for convenience.  Then,
[A]  =  [I  +  (F - 1)/(1  +  E-')]/k2. (4)
This equation states a very simple synergism in the  action of catecholamines
and phosphodiesterase  inhibitors.  In the  absence  of inhibitor  (k2 =  1),  [A]
rises  hyperbolically  from  1 to F  (Fig. 9 a).  The maintained presence  of fixed
amount  of inhibitor  gives  rise  to  a  multiplicative  increase  in  [A].  This  is
shown in Fig.  9 a by the curve labeled k2 =  0.625  (phosphodiesterase  activity
reduced  to  Y  normal).  The  cyclic  AMP  concentration  is  elevated  by  a
factor  of  1.6,  regardless  of the  concentration  of catecholamine.
Prediction of the Dose-Response Curves
The next step is to relate the level of cyclic AMP, [A],  to the eventual voltage
shift. There  is evidence  (see  Discussion)  that the cyclic AMP level continues
to rise under conditions where the voltage shift has already reached  maximum
value.  This indicates  that a  saturating  process  or  processes  links  the  rise  in
[A]  and  the eventual  effect.  Without  specifying  the  details  of the process  or
processes,  it is  useful to put the present  scheme into quantitative form and to
generate a set of theoretically  predicted dose-response curves.
Fig.  9  b shows  the  saturating  relationship  which  was  used.  It  is assumed
that the  maximal voltage  shift is produced  by something less than  a fivefold
increase  in  [A].  (The saturating  level  is shown  as a dashed line in 9 a and b.)
This assumption  is justified  by the knowledge  that the maximal  effect on  i,2
can  be evoked  by exposure to epinephrine  alone.  The form  of the saturating
relationship  is  a  quarter  sine  wave.  This  waveform  was  chosen  partly  for
convenience  of computation,  and  partly  because  the  sine  wave  gives  linear
behavior  for small A,  but an appropriately  abrupt saturation  as  A  increases.
(A  rectangular  hyperbola  does  not  saturate  abruptly  enough.)  The results
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would  not  be significantly  changed  by using  another  function  with similar
properties,  or by using a lower saturating level of [A].
A family of predicted dose-response curves  is shown in Fig.  9 c. The curves
labeled  1.0  and 0.625  can be  obtained  by combining  Fig.  9 a and  b. These
were used  in fitting the experimental  data in Fig.  7.  The other curves  were
produced  using other values  for k2 as indicated.  The results show that inhibi-
tion  of phosphodiesterase  alters  the  dose dependence  to the  catecholamine.
As  the  degree of inhibition  increases,  the normalized  dose-response  curve  is
shifted  upward  and  to the left.  The presence  of phosphodiesterase  inhibitor
lowers  the  concentration  of  catecholamine  that  is  required  to  evoke  the
maximal voltage shift. As the degree of inhibition increases,  a point is reached
(k 2 <  2/3 7r)  where the voltage  shift is maximal,  regardless  of the concentra-
tion  of  catecholamine.  This  corresponds  to  the  experimental  observation
that theophylline  in concentrations  above  5  X  10-4 M  elicits  the  maximal
voltage shift  (Fig. 4)  and occludes the effect  of epinephrine  (Fig.  5).
The form  of the  predicted  dose-response  curves  is not very  critically  de-
pendent  on the parameter  values  used  to generate  Fig.  9  c. Let As.t  be the
level  of [A]  required  to give full  effect  (A.,t  =  3r/2 in Fig.  9).  Both F and
A.,t can each be adjusted over a range of values, without qualitatively chang-
ing  the model  behavior.  The only important  requirement  is that F  2 Ast.
This point may  be  illustrated  by letting  k  increase  linearly with  E  (this  is
equivalent  to letting F become very large or making A.st small). In  this case
the  saturation  of the dose-response  curve  arises  entirely  from  the  effect  of
[A]  on  the  enzyme  system.  The  resulting  dose-response  curves  (not shown
here)  are rather similar to those  in Fig.  9 c and would  also provide  an ade-
quate fit to the experimental  data in Fig.  7. One important  conclusion from
this  analysis  is that the value  of K,  used  in fitting  the  experimental  data  is
dependent  upon  other  assumptions,  and  may  or  may  not  reflect  the  real
binding constant of epinephrine  for the P-receptor.
FIGURE  9.  The  generation  of dose-response  curves  from  the  cyclic  AMP  scheme  in
Fig. 8. 9  a shows the theoretical  relationship  between  catecholamine concentration  and
the steady level  of cyclic AMP.  9 b shows the presumed  saturating relationship between
the cyclic  AMP level and  the displacement  of V,; for A  < 3r/2, voltage  displacement
cc  sin  (A/3).  Note that  the ordinate  is labeled  so that "zero"  voltage shift occurs  at  the
resting cyclic AMP level (A  =  1).  9  c shows the normalized dose-response  curves  which
result from combining relationships of the type shown  in 9 a and b.
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Dose-Dependent Effects of Phosphodiesterase  Inhibitors
Experiments  studying  the  concentration-dependent  effects  of  phosphodies-
terase  inhibitors  were not presented  in this  paper.  However,  it  still  may  be
useful to give  corresponding  theoretical predictions  from the present scheme.
Let  us  assume that inhibitor  combines  with PDE* in a  one-for-one  manner,
converting  it to  PDE.  Then,  the  fraction  of inhibited  phosphodiesterase  is
given by the binding equation,
PDE/(PDE +  PDE*)  =  1/(1  +  T-1')  (5)
where  the  normalized  concentration  T  =  [inhibitor]  Kr,  and  K  is  the
binding  constant  of  phosphodiesterase  for  the  inhibitor.  If the uninhibited
activity  (100%  PDE*)  is  called  1 (as  above),  and  the maximally  inhibited
activity  (100%  PDE)  is  G- ,
k2  =  1 +  (G- '  - 1)/(1  +  T-').  (6)
Then from Eq.  3,
[A]  = k/k2  =  F +  E-)  /  (G  +  T-1)  (7
This  equation  emphasizes  the  similarity  between  the  effects  of E and  T.
In the  absence of phosphodiesterase  inhibitor  (T  =  0),  increasing  E causes
[A] to rise hyperbolically from  1 to F (Fig.  9 a). Analogously,  in the absence
of catecholamine  (E =  0), increasing  T causes  [A]  to rise hyperbolically from
1 to G  (not shown).  If G were  equal to F, the theoretical  dose-response curve
for theophylline  (for  T  =  0)  would have  exactly  the same form  as  the  epi-
nephrine  dose-response  curve  (for E  =  0,  Fig.  9  c).  Preliminary results  sug-
gest  that such  a relationship  may apply to the voltage shift produced  by theo-
phylline;  further  experiments  will  be  particularly  interesting  when  a  value
for  G becomes available  from biochemical studies.
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